GMI

Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer results in a 3-year survival rate of 35%.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *